title: Jekyll and Hyde: a new license for thalidomide?
authors.forename: A
authors.initials: A
authors.lastname: Saphir
mesh_terms: D000014:Abnormalities, Drug-Induced; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000970:Antineoplastic Agents; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D007880:Legislation, Drug; D011247:Pregnancy; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide